Report Highlights
The global airway management devices market reached $891.7 million in 2022 and should reach $1.1 billion by 2027, with a compound annual growth rate (CAGR) of 5.5% during the forecast period of 2022-2027.
Report Includes
- 38 data tables and 60 additional tables
- A brief general outlook of the global market for airway management devices
- Analyses of the global market trends, with historic market revenue (sales figures) from 2020-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the upcoming market potential for airway management device and innovation-driven applications, and the major regions and countries involved in such developments
- Estimation of the actual market size and revenue forecast for airway management device in USD million values, and corresponding market share analysis based on type, application, end-user, and region
- Coverage of the technological, economic, and business considerations of airway management device market, with global market data analyses and growth forecasts through 2027
- Identification of the major stakeholders and analysis of the company competitive landscape based on recent developments, financial performance, and segmental revenues
- Company profiles of major players within the industry, including Cardinal Health Inc., ConvaTec Inc., ICU Medical Inc., Medtronics Inc. and Teleflex Inc.
Report Scope
This research report categorizes the market for airway management devices by product segment. The major product segments are Infraglottic Airway Management, Supraglottic Airway Management, Laryngoscope, and Cricothyrotomy Kits. Infraglottic devices are divided into Endotracheal Tubes and Tracheostomy Tubes. Supraglottic devices are divided into Laryngeal Mask Airways, Oropharyngeal Airway Nasopharyngeal Airway, and Other Supraglottic Airway management devices. Laryngoscopes are segmented into Conventional Laryngoscope and Video Laryngoscope.
The global market for airway management is segmented by patient age (into adult and pediatric patient) and by end user (into hospitals, emergency departments, ICU, and others). The markets in North America, Europe, Asia-Pacific, and Rest of the World (RoW) are covered.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2021 | ||||||||||||||||||
| Forecast period considered | 2022-2027 | ||||||||||||||||||
| Base year market size | $853.3 million | ||||||||||||||||||
| Market size forecast | $1.1 billion | ||||||||||||||||||
| Growth rate | CAGR of 5.5% for the forecast period of 2022-2027 | ||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||
| Segments covered | Product Segment, Patient Age, End User, Region | ||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (RoW) | ||||||||||||||||||
| Countries covered | U.S., Canada, Germany, France, U.K., China, India, Japan, South America, Middle East and Africa | ||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||
| Companies studied |
|
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Anesthesia and Respiratory Devices: Global Markets
The global anesthesia and respiratory devices market should reach $36.2 billion by 2022 and more than $51 billion by 2027, with a compound annual growth rate (CAGR) of 7.1% during the forecast period of 2022-2027.
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical device technologies should grow from $81.9 billion in 2020 to $146.2 billion by 2025, at compound annual growth rate (CAGR) of 12.3% for the period of 2020-2025.
Ambulance and Emergency Equipment: Global Markets
The global ambulance and emergency equipment market should reach $8.9 billion by 2025 from $7.7 billion in 2020 at a compound annual growth rate (CAGR) of 2.9% for the forecast period of 2020 to 2025.
Recent Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More